Hooker Furniture to Host Third Quarter Earnings Call December 7
Nov 03, 2016 11:40 am UTC| Business
MARTINSVILLE, Va., Nov. 03, 2016 -- Hooker Furniture Corporation (Nasdaq:HOFT) will present its fiscal 2017 third quarter results via teleconference and live internet web cast on Wednesday afternoon, December 7 at 2:00...
PARC and the Malaysia Digital Economy Corporation (MDEC) Launch Silicon Valley Innovation Program
Nov 03, 2016 11:38 am UTC| Business
Palo Alto, CA, Nov. 03, 2016 -- PARC, a Xerox company, and the Malaysia Digital Economy Corporation (MDEC), through its United States entity MDeC Americas Inc, today announced a new program to offer innovation training,...
Matinas BioPharma Researchers Among Rutgers University Recipients of 2016 Edison Patent Awards
Nov 03, 2016 11:35 am UTC| Business
BEDMINSTER, N.J., Nov. 03, 2016 -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the...
Genocea Reports Third Quarter 2016 Financial Results
Nov 03, 2016 11:30 am UTC| Business
- Positive Phase 2b results recently reported and dose selected forGEN-003 Phase 3 program expected to initiate in 2H 2017 - - Conference Call at 9am ET today - CAMBRIDGE, Mass., Nov. 03, 2016 -- Genocea...
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2016 Financial Results
Nov 03, 2016 11:30 am UTC| Business
RADNOR, Pa., Nov. 03, 2016 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and other neuropsychiatric disorders,...
Nov 03, 2016 11:30 am UTC| Business
CORALVILLE, Iowa, Nov. 03, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced it has appealed the...
Conatus Initiates Phase 2b ENCORE-PH Clinical Trial of Emricasan in Patients with NASH Cirrhosis
Nov 03, 2016 11:30 am UTC| Business
SAN DIEGO, Nov. 03, 2016 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today announced the initiation of ENCORE-PH (PH for Portal Hypertension), a randomized, double-blind, placebo-controlled, Phase 2b clinical trial...
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.